Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Track This Opportunity
Create an account to track opportunities.
About This Opportunity
This is a federal grant opportunity from the National Institutes of Health (NIH) for early-stage companies or researchers developing innovative technologies for basic and clinical cancer research. Successful applicants will receive funding to advance their technology development efforts.
Eligibility Requirements
Application Guide
Selection will be based on the innovation and potential impact of the technology on basic and clinical cancer research, and the feasibility of the early-stage development plan.
Clearly articulate the novelty and significance of your technology for cancer research. Provide a detailed and well-justified plan for early-stage development.
Geographic Coverage
Links & Resources
Source & freshness
Last verified: 8/12/2026
Primary source: Official source page
Refresh cadence: Listings are refreshed weekly.
Reminder: Confirm eligibility and deadlines before applying.